Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma
Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Background
ZMYND8 (Zinc finger MYND (Myeloid, Nervy and DEAF-1)-type containing 8)
has been known to play an important role in tumor regulation in various types of cancer. However, the results of
ZMYND8
expression and their clinical significance in hepatocellular carcinoma (HCC) have not yet been published. In the present study, we inve...
Alternative Titles
Full title
Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2567988643
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2567988643
Other Identifiers
ISSN
0171-5216
E-ISSN
1432-1335
DOI
10.1007/s00432-021-03768-3
